Calidi Biotherapeutics, Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
CLDI on NYSE, CLDWW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
4475 Executive Drive, Suite 200, San Diego, CA

Insiders trading volume in the past year

Calidi Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Polar Asset Management Partners Inc. 10%+ Owner $4.33M Oct 19, 2022
Stephen Thesing Chief Business Officer $849K Sep 12, 2023
Boris Radoslavov Minev Interim Chief Medical Officer $764K Jun 17, 2024
Thomas Vecchiolla Director $657K Dec 21, 2023
Antonio Fernandez SVP, Global Head of R&D $590K Sep 12, 2023
Tony Kalajian Chief Acctg Officer, Int. CFO $502K Sep 12, 2023
Heehyoung Lee Director, Former Director $444K Oct 10, 2023
Wendy Pizarro Campbell Chief Admin. and Legal Officer $292K Jun 17, 2024
Alfonso G. Zulueta Director $240K Dec 21, 2023
James A. Schoeneck Director $214K Sep 20, 2024
Scott Leftwich Director $112K Sep 20, 2024
Allan Camaisa CEO and Chairman of the Board, Director $108K -$16.2K -13% Dec 17, 2024
Amish Patel VP of Technical Operations $52.7K Sep 12, 2023
George Ng Director $50.6K Sep 12, 2023
David Sans Chief of Corporate Development $33K Sep 12, 2023
Alan R. Stewart Director $30.8K Sep 20, 2024
David LaPre Director Jan 1, 2024
George Peoples Director Sep 20, 2024
Andrew Jackson Chief Financial Officer Jun 17, 2024
First Light Acquisition Group, LLC 10%+ Owner Jun 16, 2023
Michael J. Alber Chief Financial Officer Sep 9, 2021
Michael Ruettgers Director Sep 9, 2021
William Fallon Director Sep 9, 2021
Jeanne Tisinger Director Sep 9, 2021
William John Weber Chief Executive Officer, Director, 10%+ Owner Sep 9, 2021
Hudson Bay Capital Management LP 10%+ Owner Sep 12, 2023

Recent Insider Transactions by Companies or Individuals for Calidi Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.